Neuronity Therapeutics
Mansfield
About Neuronity Therapeutics
Neuronity cures neurological disorders by promoting immunity of the central nervous system. Neuronity was founded in 2022 and was headquartered in Mansfield, United States.
Company Facts
- Operating status: Active
- Company type: For Profit
- IPO status: Private
- Employees: 1 – 10
- Total funding: $780.0K
- Last round: Grant (Jul 2023)
- Website: neuronitytx.com
- Phone: 617-299-6262
Industries & Categories
Life Science
Social Profiles
Canonical: https://fsome.com/organization/neuronity-therapeutics-95000 · For the full interactive profile (charts, investors, team, acquisitions, press), please enable JavaScript.